eISSN: 2345-6558

Free Access

Journal of Parathyroid Disease 2014;2(1):1-2
Secondary Hyperparathyroidism in chronic kidney disease patients; current knowledge

Hypothesis

Masoud Amiri 1, Hamid Nasri 2 *

1 Social Health Determinants Research Center, Shahrekord University of Medical Sciences Shahrekord, Iran.
2 Department of Nephrology, Division of Nephropathology, Isfahan University of Medical Sciences, Isfahan, Iran.


*Corresponding author: Prof. Hamid Nasri,
Email: hamidnasri@med.mui.ac.ir


Notes

Implication for health policy/practice/research/medical education

Secondary hyperparathyroidism is a progressive disease common in patients with chronic renal failure and with serious concerns for patient health. If unsuccessfully controlled, secondary hyperparathyroidism develops and can lead to soft tissue calcification, bone disease, and vascular calcification, which adversely impact mortality and morbidity. Conventional therapies that target vitamin D and phosphorous levels are not without disadvantages. The appearance of the calcimimetics and a better understanding of the strengths and limitations of native and active vitamin D compounds have advanced the treatment options for patients with secondary hyperparathyroidism.

Please cite this paper as: Amiri M, Nasri H. Secondary Hyperparathyroidism in chronic kidney disease patients; current knowledge. J Parathyr Dis 2014; 2(1): 1-2.


Comments
First name  
Last name  
Email address  
Comments  
Security code



Article
PDF


Export citation
EndNote
Reference Manager
BibTeX
Medlars
Refworks

Cite by
Google Scholar

Google Scholar
Articles by Masoud Amiri
Articles by Hamid Nasri
Similar articles
Related articles

PubMed
Articles by Masoud Amiri
Articles by Hamid Nasri


Article Access Statistics
Viewed
PDF Downloaded
Comments

Share this article!
Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute